Skip to main content
Clinical Trials/NCT05602584
NCT05602584
Enrolling By Invitation
Not Applicable

The Effect of Immunophenotype on Prognosis of Sepsis

Southeast University, China1 site in 1 country200 target enrollmentOctober 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Sepsis
Sponsor
Southeast University, China
Enrollment
200
Locations
1
Primary Endpoint
survival or death in 28 days
Status
Enrolling By Invitation
Last Updated
3 years ago

Overview

Brief Summary

The popuse of this study is to assess the inflammatory immunophenotypes of sepsis patients are significantly correlated with prognosis, which may provide theoretical basis for precise immune regulation of sepsis.

Detailed Description

The clinical characteristics and inflammatory/immune markers of sepsis patients were analyzed dynamically and followed up to one year after diagnosis. Through latent category analysis, cluster analysis and other inflammatory immunophenotypes, the clinical characteristics of different inflammatory immunophenotypes and their relationship with the long-term prognosis of sepsis were clarified.

Registry
clinicaltrials.gov
Start Date
October 1, 2021
End Date
December 1, 2023
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Southeast University, China
Responsible Party
Principal Investigator
Principal Investigator

Jianfeng Xie

Clinical Professor

Southeast University, China

Eligibility Criteria

Inclusion Criteria

  • Patients with sepsis 3 diagnostic criteria were admitted to ICU; Aged 18 or above; Within 24 hours of diagnosis.

Exclusion Criteria

  • Malignant tumor; Autoimmune diseases; Diseases of the blood system; HIV infection; History of high-dose glucocorticoid use (hydrocortisone 200mg/d or other hormone with equivalent titer, more than one week); pregnancy

Outcomes

Primary Outcomes

survival or death in 28 days

Time Frame: From date of randomization until the date of out of ICU or date of death from any cause, whichever came first, assessed up to 28 days

observe wether the patients is survival or death in 28 days

Study Sites (1)

Loading locations...

Similar Trials